APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Nifedipine Controlled-release Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nifedipine Controlled-release Tablets Market Outlook and Growth Opportunities 2026

Report ID 174017020429 December 2025193 pages

Choose your research edition.

Industry ResearchNifedipine Controlled-release Tablets Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Nifedipine Controlled-release Tablets Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Nifedipine Controlled-release Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nifedipine Controlled-release Tablets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Nifedipine Controlled-release Tablets Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Nifedipine Controlled-release Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nifedipine Controlled-release Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nifedipine Controlled-release Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nifedipine Controlled-release Tablets market include Simcere, Shanghai Shyndec Pharma, Qingdao Baiyang Pharmaceutical, China Resources Double Crane Limin Pharmaceutical (Jinan), Hefei Cube Pharma, Bayer, Nanjing EASEHEAL Pharma, Deyao Pharma and Beijing Honglin Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nifedipine Controlled-release Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nifedipine Controlled-release Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nifedipine Controlled-release Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nifedipine Controlled-release Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Nifedipine Controlled-release Tablets Segment by Company

Simcere

Shanghai Shyndec Pharma

Qingdao Baiyang Pharmaceutical

China Resources Double Crane Limin Pharmaceutical (Jinan)

Hefei Cube Pharma

Bayer

Nanjing EASEHEAL Pharma

Deyao Pharma

Beijing Honglin Pharma

Apichope

Nifedipine Controlled-release Tablets Segment by Type

Generic Drug

Original Drug

Nifedipine Controlled-release Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Nifedipine Controlled-release Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nifedipine Controlled-release Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nifedipine Controlled-release Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nifedipine Controlled-release Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Nifedipine Controlled-release Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nifedipine Controlled-release Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nifedipine Controlled-release Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nifedipine Controlled-release Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nifedipine Controlled-release Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nifedipine Controlled-release Tablets industry.

Chapter 3: Detailed analysis of Nifedipine Controlled-release Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nifedipine Controlled-release Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nifedipine Controlled-release Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nifedipine Controlled-release Tablets Industry Trends Table 2. Nifedipine Controlled-release Tablets Industry Drivers Table 3. Nifedipine Controlled-release Tablets Industry Opportunities and Challenges Table 4. Nifedipine Controlled-release Tablets Industry Restraints Table 5. Global Nifedipine Controlled-release Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nifedipine Controlled-release Tablets Revenue Share by Company (2021-2026) Table 7. Global Nifedipine Controlled-release Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Nifedipine Controlled-release Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Nifedipine Controlled-release Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Nifedipine Controlled-release Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nifedipine Controlled-release Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Nifedipine Controlled-release Tablets Company, Product Type & Application Table 13. Global Nifedipine Controlled-release Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nifedipine Controlled-release Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Generic Drug Table 18. Significant Companies of Original Drug Table 19. Global Nifedipine Controlled-release Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Nifedipine Controlled-release Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Nifedipine Controlled-release Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Nifedipine Controlled-release Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Nifedipine Controlled-release Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Nifedipine Controlled-release Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Nifedipine Controlled-release Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Nifedipine Controlled-release Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Nifedipine Controlled-release Tablets Sales Value Share by Type (2021-2026) Table 28. Global Nifedipine Controlled-release Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Retail Pharmacies Table 31. Significant Companies of Other Table 32. Global Nifedipine Controlled-release Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Nifedipine Controlled-release Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Nifedipine Controlled-release Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Nifedipine Controlled-release Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Nifedipine Controlled-release Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Nifedipine Controlled-release Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Nifedipine Controlled-release Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Nifedipine Controlled-release Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Nifedipine Controlled-release Tablets Sales Value Share by Application (2021-2026) Table 41. Global Nifedipine Controlled-release Tablets Sales Value Share by Application (2027-2032) Table 42. Global Nifedipine Controlled-release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Nifedipine Controlled-release Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Nifedipine Controlled-release Tablets Sales Market Share by Region (2021-2026) Table 45. Global Nifedipine Controlled-release Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Nifedipine Controlled-release Tablets Sales Market Share by Region (2027-2032) Table 47. Global Nifedipine Controlled-release Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Nifedipine Controlled-release Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Nifedipine Controlled-release Tablets Sales Value Share by Region (2021-2026) Table 50. Global Nifedipine Controlled-release Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Nifedipine Controlled-release Tablets Sales Value Share by Region (2027-2032) Table 52. Global Nifedipine Controlled-release Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Nifedipine Controlled-release Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Nifedipine Controlled-release Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Nifedipine Controlled-release Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Nifedipine Controlled-release Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Nifedipine Controlled-release Tablets Sales Market Share by Country (2021-2026) Table 58. Global Nifedipine Controlled-release Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Nifedipine Controlled-release Tablets Sales Market Share by Country (2027-2032) Table 60. Global Nifedipine Controlled-release Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Nifedipine Controlled-release Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Nifedipine Controlled-release Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Nifedipine Controlled-release Tablets Sales Value Market Share by Country (2027-2032) Table 64. Simcere Company Information Table 65. Simcere Business Overview Table 66. Simcere Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Simcere Nifedipine Controlled-release Tablets Product Portfolio Table 68. Simcere Recent Development Table 69. Shanghai Shyndec Pharma Company Information Table 70. Shanghai Shyndec Pharma Business Overview Table 71. Shanghai Shyndec Pharma Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Shanghai Shyndec Pharma Nifedipine Controlled-release Tablets Product Portfolio Table 73. Shanghai Shyndec Pharma Recent Development Table 74. Qingdao Baiyang Pharmaceutical Company Information Table 75. Qingdao Baiyang Pharmaceutical Business Overview Table 76. Qingdao Baiyang Pharmaceutical Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Qingdao Baiyang Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio Table 78. Qingdao Baiyang Pharmaceutical Recent Development Table 79. China Resources Double Crane Limin Pharmaceutical (Jinan) Company Information Table 80. China Resources Double Crane Limin Pharmaceutical (Jinan) Business Overview Table 81. China Resources Double Crane Limin Pharmaceutical (Jinan) Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. China Resources Double Crane Limin Pharmaceutical (Jinan) Nifedipine Controlled-release Tablets Product Portfolio Table 83. China Resources Double Crane Limin Pharmaceutical (Jinan) Recent Development Table 84. Hefei Cube Pharma Company Information Table 85. Hefei Cube Pharma Business Overview Table 86. Hefei Cube Pharma Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Hefei Cube Pharma Nifedipine Controlled-release Tablets Product Portfolio Table 88. Hefei Cube Pharma Recent Development Table 89. Bayer Company Information Table 90. Bayer Business Overview Table 91. Bayer Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Bayer Nifedipine Controlled-release Tablets Product Portfolio Table 93. Bayer Recent Development Table 94. Nanjing EASEHEAL Pharma Company Information Table 95. Nanjing EASEHEAL Pharma Business Overview Table 96. Nanjing EASEHEAL Pharma Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Nanjing EASEHEAL Pharma Nifedipine Controlled-release Tablets Product Portfolio Table 98. Nanjing EASEHEAL Pharma Recent Development Table 99. Deyao Pharma Company Information Table 100. Deyao Pharma Business Overview Table 101. Deyao Pharma Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Deyao Pharma Nifedipine Controlled-release Tablets Product Portfolio Table 103. Deyao Pharma Recent Development Table 104. Beijing Honglin Pharma Company Information Table 105. Beijing Honglin Pharma Business Overview Table 106. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product Portfolio Table 108. Beijing Honglin Pharma Recent Development Table 109. Apichope Company Information Table 110. Apichope Business Overview Table 111. Apichope Nifedipine Controlled-release Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Apichope Nifedipine Controlled-release Tablets Product Portfolio Table 113. Apichope Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Nifedipine Controlled-release Tablets Distributors List Table 117. Nifedipine Controlled-release Tablets Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Nifedipine Controlled-release Tablets Product Image Figure 2. Global Nifedipine Controlled-release Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nifedipine Controlled-release Tablets Sales (2021-2032) & (K Units) Figure 5. Global Nifedipine Controlled-release Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Nifedipine Controlled-release Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Generic Drug Image Figure 10. Original Drug Image Figure 11. Global Nifedipine Controlled-release Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Nifedipine Controlled-release Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Nifedipine Controlled-release Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Nifedipine Controlled-release Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Nifedipine Controlled-release Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Nifedipine Controlled-release Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Retail Pharmacies Image Figure 19. Other Image Figure 20. Global Nifedipine Controlled-release Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Nifedipine Controlled-release Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Nifedipine Controlled-release Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Nifedipine Controlled-release Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Nifedipine Controlled-release Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Nifedipine Controlled-release Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Nifedipine Controlled-release Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Nifedipine Controlled-release Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Nifedipine Controlled-release Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Nifedipine Controlled-release Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Nifedipine Controlled-release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Nifedipine Controlled-release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Nifedipine Controlled-release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Nifedipine Controlled-release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Nifedipine Controlled-release Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Nifedipine Controlled-release Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Nifedipine Controlled-release Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Nifedipine Controlled-release Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Generic Drug
  • Original Drug
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Simcere
  • Shanghai Shyndec Pharma
  • Qingdao Baiyang Pharmaceutical
  • China Resources Double Crane Limin Pharmaceutical (Jinan)
  • Hefei Cube Pharma
  • Bayer
  • Nanjing EASEHEAL Pharma
  • Deyao Pharma
  • Beijing Honglin Pharma
  • Apichope

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Nifedipine Controlled-release Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Nifedipine Controlled-release Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nifedipine Controlled-release Tablets Market Dynamics
  1. 2.1 Nifedipine Controlled-release Tablets Industry Trends
  2. 2.2 Nifedipine Controlled-release Tablets Industry Drivers
  3. 2.3 Nifedipine Controlled-release Tablets Industry Opportunities and Challenges
  4. 2.4 Nifedipine Controlled-release Tablets Industry Restraints
3 Nifedipine Controlled-release Tablets Market by Company
  1. 3.1 Global Nifedipine Controlled-release Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Nifedipine Controlled-release Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Nifedipine Controlled-release Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Nifedipine Controlled-release Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Nifedipine Controlled-release Tablets Company Ranking (2024-2026)
  6. 3.6 Global Nifedipine Controlled-release Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Nifedipine Controlled-release Tablets Company Product Type and Application
  8. 3.8 Global Nifedipine Controlled-release Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nifedipine Controlled-release Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nifedipine Controlled-release Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nifedipine Controlled-release Tablets Market by Type
  1. 4.1 Nifedipine Controlled-release Tablets Type Introduction
  2. 4.1.1 Generic Drug
  3. 4.1.2 Original Drug
  4. 4.2 Global Nifedipine Controlled-release Tablets Sales Volume by Type
  5. 4.2.1 Global Nifedipine Controlled-release Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Nifedipine Controlled-release Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Nifedipine Controlled-release Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Nifedipine Controlled-release Tablets Sales Value by Type
  9. 4.3.1 Global Nifedipine Controlled-release Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Nifedipine Controlled-release Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Nifedipine Controlled-release Tablets Sales Value Share by Type (2021-2032)
5 Nifedipine Controlled-release Tablets Market by Application
  1. 5.1 Nifedipine Controlled-release Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Other
  5. 5.2 Global Nifedipine Controlled-release Tablets Sales Volume by Application
  6. 5.2.1 Global Nifedipine Controlled-release Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nifedipine Controlled-release Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Nifedipine Controlled-release Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Nifedipine Controlled-release Tablets Sales Value by Application
  10. 5.3.1 Global Nifedipine Controlled-release Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Nifedipine Controlled-release Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Nifedipine Controlled-release Tablets Sales Value Share by Application (2021-2032)
6 Nifedipine Controlled-release Tablets Regional Sales and Value Analysis
  1. 6.1 Global Nifedipine Controlled-release Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nifedipine Controlled-release Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Nifedipine Controlled-release Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Nifedipine Controlled-release Tablets Sales by Region (2027-2032)
  5. 6.3 Global Nifedipine Controlled-release Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nifedipine Controlled-release Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nifedipine Controlled-release Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nifedipine Controlled-release Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Nifedipine Controlled-release Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Nifedipine Controlled-release Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Nifedipine Controlled-release Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nifedipine Controlled-release Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Nifedipine Controlled-release Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nifedipine Controlled-release Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nifedipine Controlled-release Tablets Sales Value Share by Country, 2025 VS 2032
7 Nifedipine Controlled-release Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Nifedipine Controlled-release Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nifedipine Controlled-release Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nifedipine Controlled-release Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Nifedipine Controlled-release Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Nifedipine Controlled-release Tablets Sales by Country (2027-2032)
  6. 7.4 Global Nifedipine Controlled-release Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nifedipine Controlled-release Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nifedipine Controlled-release Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nifedipine Controlled-release Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nifedipine Controlled-release Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nifedipine Controlled-release Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Simcere
  2. 8.1.1 Simcere Company Information
  3. 8.1.2 Simcere Business Overview
  4. 8.1.3 Simcere Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Simcere Nifedipine Controlled-release Tablets Product Portfolio
  6. 8.1.5 Simcere Recent Developments
  7. 8.2 Shanghai Shyndec Pharma
  8. 8.2.1 Shanghai Shyndec Pharma Company Information
  9. 8.2.2 Shanghai Shyndec Pharma Business Overview
  10. 8.2.3 Shanghai Shyndec Pharma Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanghai Shyndec Pharma Nifedipine Controlled-release Tablets Product Portfolio
  12. 8.2.5 Shanghai Shyndec Pharma Recent Developments
  13. 8.3 Qingdao Baiyang Pharmaceutical
  14. 8.3.1 Qingdao Baiyang Pharmaceutical Company Information
  15. 8.3.2 Qingdao Baiyang Pharmaceutical Business Overview
  16. 8.3.3 Qingdao Baiyang Pharmaceutical Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qingdao Baiyang Pharmaceutical Nifedipine Controlled-release Tablets Product Portfolio
  18. 8.3.5 Qingdao Baiyang Pharmaceutical Recent Developments
  19. 8.4 China Resources Double Crane Limin Pharmaceutical (Jinan)
  20. 8.4.1 China Resources Double Crane Limin Pharmaceutical (Jinan) Company Information
  21. 8.4.2 China Resources Double Crane Limin Pharmaceutical (Jinan) Business Overview
  22. 8.4.3 China Resources Double Crane Limin Pharmaceutical (Jinan) Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 China Resources Double Crane Limin Pharmaceutical (Jinan) Nifedipine Controlled-release Tablets Product Portfolio
  24. 8.4.5 China Resources Double Crane Limin Pharmaceutical (Jinan) Recent Developments
  25. 8.5 Hefei Cube Pharma
  26. 8.5.1 Hefei Cube Pharma Company Information
  27. 8.5.2 Hefei Cube Pharma Business Overview
  28. 8.5.3 Hefei Cube Pharma Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hefei Cube Pharma Nifedipine Controlled-release Tablets Product Portfolio
  30. 8.5.5 Hefei Cube Pharma Recent Developments
  31. 8.6 Bayer
  32. 8.6.1 Bayer Company Information
  33. 8.6.2 Bayer Business Overview
  34. 8.6.3 Bayer Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bayer Nifedipine Controlled-release Tablets Product Portfolio
  36. 8.6.5 Bayer Recent Developments
  37. 8.7 Nanjing EASEHEAL Pharma
  38. 8.7.1 Nanjing EASEHEAL Pharma Company Information
  39. 8.7.2 Nanjing EASEHEAL Pharma Business Overview
  40. 8.7.3 Nanjing EASEHEAL Pharma Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Nanjing EASEHEAL Pharma Nifedipine Controlled-release Tablets Product Portfolio
  42. 8.7.5 Nanjing EASEHEAL Pharma Recent Developments
  43. 8.8 Deyao Pharma
  44. 8.8.1 Deyao Pharma Company Information
  45. 8.8.2 Deyao Pharma Business Overview
  46. 8.8.3 Deyao Pharma Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Deyao Pharma Nifedipine Controlled-release Tablets Product Portfolio
  48. 8.8.5 Deyao Pharma Recent Developments
  49. 8.9 Beijing Honglin Pharma
  50. 8.9.1 Beijing Honglin Pharma Company Information
  51. 8.9.2 Beijing Honglin Pharma Business Overview
  52. 8.9.3 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Beijing Honglin Pharma Nifedipine Controlled-release Tablets Product Portfolio
  54. 8.9.5 Beijing Honglin Pharma Recent Developments
  55. 8.10 Apichope
  56. 8.10.1 Apichope Company Information
  57. 8.10.2 Apichope Business Overview
  58. 8.10.3 Apichope Nifedipine Controlled-release Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Apichope Nifedipine Controlled-release Tablets Product Portfolio
  60. 8.10.5 Apichope Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nifedipine Controlled-release Tablets Value Chain Analysis
  2. 9.1.1 Nifedipine Controlled-release Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nifedipine Controlled-release Tablets Sales Mode & Process
  6. 9.2 Nifedipine Controlled-release Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nifedipine Controlled-release Tablets Distributors
  9. 9.2.3 Nifedipine Controlled-release Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst